

Publisher: Bentham Science Publishers
E-ISSN: 1873-5592|12|14|2045-2058
ISSN: 1389-4501
Source: Current Drug Targets, Vol.12, Iss.14, 2011-12, pp. : 2045-2058
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


By Varkaris Andreas Corn Paul G Gaur Sanchaika Dayyani Farshid Logothetis Christopher J Gallick Gary E
Expert Opinion on Investigational Drugs, Vol. 20, Iss. 12, 2011-12 ,pp. :


The emergence of resistance to targeted cancer therapeutics
By Mellinghoff Ingo K Sawyers Charles L
Pharmacogenomics, Vol. 3, Iss. 5, 2002-09 ,pp. :


Bcl-2-targeted cancer therapeutics
By Khorchid Amani Beauparlant Pierre
Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 6, 2004-06 ,pp. :

